Abstracts Archive - Page 1493 of 2607 - ACR Meeting Abstracts

Abstract Number: 1586 • 2017 ACR/ARHP Annual Meeting
Resistant Hypertension Is Associated with Inflammation, Renal Function, and Increased Mortality in Patients with Systemic Lupus Erythematosus
Jocelyn Gandelman¹, Megan Shuey², April Barnado³, Li Wang⁴, C. Michael Stein³ and Cecilia P. Chung³, ¹Vanderbilt University School of Medicine, Nashville, TN, ²Department of Pharmacology, Vanderbilt University, Nashville, TN, ³Medicine, Vanderbilt University Medical Center, Nashville, TN, ⁴Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
Background/Purpose: Resistant hypertension (RHTN) is defined as blood pressure that remains >140/90 mm Hg despite concurrent use of three different antihypertensive drugs. RHTN has an…
Abstract Number: 1587 • 2017 ACR/ARHP Annual Meeting
Mycobacterial Infection in Systemic Lupus Erythematosus: Clinical Significance and Associated Factors. Data from the Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)
Ana Lois-Iglesias¹, Víctor del Campo-Pérez², Iñigo Rúa-Figueroa³, Coral Mouriño-Rodriguez⁴, Francisco Javier López Longo⁵, María Galindo⁶, Jaime Calvo-Alen⁷, Jesús Ibañez Ruán⁸, Alejandro Olivé⁹, Rafael-Benito Melero González⁴, Antonio Fernandez-Nebro¹⁰, José Antonio Bernal¹¹, Celia Erausquin¹², Eva Tomero¹³, Maria Loreto Horcada¹⁴, Esther Uriarte¹⁵, Mercedes Freire¹⁶, Carlos Alberto Montilla-Morales¹⁷, Ana Sánchez Atrio¹⁸, Alina Boteanu¹⁹, Elvira Diez Alvarez²⁰, Javier Narváez²¹, Víctor Martínez Taboada²², Lucía Silva Fernández²³, Esther Ruiz Lucea²⁴, Jose Luis Andreu²⁵, José Hernández Beiraín²⁶, Marian Gantes²⁷, Blanca Hernández-Cruz²⁸, Jose Javier Perez Venegas²⁹, Ángela Pecondón Español³⁰, Nuria Lozano-Rivas³¹, Monica Ibanez Barcelo³², Gema Bonilla³³, Vicente Torrente³⁴, Ivan Castellví³⁵, Juan José Alegre³⁶, Mireia Moreno³⁷, José Luis Marenco de la Fuente³⁸, Cesar Magro-Checa³⁹, Tomás Vázquez Rodríguez⁴⁰, Victor Quevedo⁴¹, Patricia Richi⁴², Maria Teresa Oton Sanchez⁴³ and JM Pego-Reigosa⁴⁴, ¹Rheumatology, University Hospital A Coruña, A Coruña, Spain, ²Preventive Medicine and Epidemiology, EOXI Vigo, Vigo, Spain, ³Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, ⁴Rheumatology, EOXI Vigo, Vigo, Spain, ⁵Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, ⁶Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, ⁷Rheumatology, Txagorritxu Hospital, Araba, Vitoria, Vitoria, Spain, ⁸POVISA, Rheumatology, Vigo, Spain, ⁹Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, ¹⁰Rheumatology, Regional Universitary Hospital of Málaga, Malaga, Spain, ¹¹Reumatología, Hospital Universitario del Vinalopó, Elche, Spain, ¹²Rheumatology, Hospital de Gran Canaria Dr Negrin, Las Palmas GC, Spain, ¹³Hospital La Princesa. Madrid., Madrid, Spain, ¹⁴Rheumatology, Complejo Hospitalario de Navarra, Pamplona, Spain, ¹⁵Reumatología, Hospital de Donosti, Donosti, Spain, ¹⁶Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo HospitalarioUniversitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, ¹⁷Hospital Clínico Universitario de Salamanca, Salamanca, Spain, ¹⁸University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology Department, Alcalá de Henares, Madrid, Spain, ¹⁹University Hospital Ramón y Cajal, Madrid, Spain, ²⁰Complejo Asistencial Universitario de León. León. Spain, León, Spain, ²¹Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, ²²Rheumatology, Hospital Marqués de Valdecilla, Santander, Spain, ²³Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, ²⁴Hospital de Basurto, Bilbao, Spain, ²⁵Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, ²⁶Rheumatology, Hospital Insular de Gran Canaria, Las palmas Gran Canarias, Spain, ²⁷Rheumatology, Hospital Universitario de Canarias, La Laguna; Tenerife, Spain, ²⁸Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, ²⁹Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, ³⁰Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ³¹Rheumatology, Hospital Virgen de la Arrixaca, murcia, Spain, ³²H. Son Llatzer, Palma de Mallorca, Spain, ³³Hospital Universitario La Paz, Madrid, Spain, ³⁴Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain, ³⁵Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, ³⁶Sección de Reumatología Hospital Universitario Dr Peset Valencia, Valencia, Spain, ³⁷Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Spain, ³⁸Rheumatology, Hospital de Valme, Seville, Spain, ³⁹Department of Rheumatology, Leiden University Medical Center, Leiden, Spain, ⁴⁰Rheumatology, Hospital Lucus Augusti, Lugo, Spain, ⁴¹Rheumatology, Hospital de Monforte, Lugo, Spain, ⁴²Hospital Infanta Sofía, Madrid, Spain, ⁴³Rheumatology Department. Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain, ⁴⁴Rheumatology Section, Hospital de Meixoeiro, Pontevedra, Spain, Vigo, Spain
Background/Purpose: The aim of this work is to study the prevalence of mycobacterial infection (M.I.), the associated factors and their clinical significance in patients included…
Abstract Number: 1588 • 2017 ACR/ARHP Annual Meeting
“Neoplasia in Patients with Systemic LUPUS Erythematosus in Spain: Relesser Registry DATA”
Ana Urruticoechea-Arana¹, Iñigo Rúa-Figueroa², Maria Auxiliadora Martin³, Fernando Sánchez-Alonso⁴, Francisco Javier López Longo⁵, María Galindo⁶, Alejandro Olivé⁷, Jaime Calvo-Alen⁸, Antonio Fernandez-Nebro⁹ and JM Pego-Reigosa¹⁰, ¹Rheumatology, Hospital de Can Mises, Ibiza, Spain, ²Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, ³Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, ⁴Unidad de Investigación, Spanish Society of Rheumatology, Madrid, Spain, ⁵Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, ⁶Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, ⁷Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, ⁸Rheumatology, Txagorritxu Hospital, Araba, Vitoria, Vitoria, Spain, ⁹Rheumatology, Regional Universitary Hospital of Málaga, Malaga, Spain, ¹⁰Rheumatology Section, Hospital de Meixoeiro, Pontevedra, Spain, Vigo, Spain
Background/Purpose: There is limited evidence on the risk of neoplasia in autoimmune diseases such as systemic lupus erythematosus. The objective of this study is to…
Abstract Number: 1589 • 2017 ACR/ARHP Annual Meeting
A Multicriteria Decision Analysis for the Development of New Systemic Lupus Erythematosus Classification Criteria
Sara K. Tedeschi¹, Sindhu Johnson², Dimitrios Boumpas³, David I. Daikh⁴, Betty Diamond⁵, Thomas Doerner⁶, Søren Jacobsen⁷, Diane L. Kamen⁸, W. Joseph McCune⁹, Marta Mosca¹⁰, Rosalind Ramsey-Goldman¹¹, Guillermo Ruiz-Irastorza¹², Matthias Schneider¹³, Josef S. Smolen¹⁴, Murray Urowitz¹⁵, David Wofsy¹⁶, Martin Aringer¹⁷, Raymond P. Naden¹⁸ and Karen H. Costenbader^19,20, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Rheumatology, Mount Sinai Hospital and University Health Network, Toronto, ON, Canada, ³University of Athens, Athens, Greece, ⁴Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁵Feinstein Institute for Medical Research, Manhasset, NY, ⁶Charité Universitätmedizin Berlin and DRFZ, Berlin, Germany, ⁷Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark, ⁸Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ⁹Int Med/ Rheum, University of Michigan, Ann Arbor, MI, ¹⁰Rheumatology Unit, University of Pisa, Pisa, Italy, ¹¹FSM, Northwestern University, Chicago, IL, ¹²Autoimmune Diseases Research Unit, BioCruces, Hospital Universitario Cruces, Baracaldo, Spain, ¹³Policlinic for Rheumatology & Hiller Research Centre for Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, ¹⁴Division of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ¹⁵Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ¹⁶Rheumatology, UCSF, San Francisco, CA, ¹⁷Medicine III, University Medical Center and Faculty of Medicine at the TU Dresden, Dresden, Germany, ¹⁸New Zealand Ministry of Health, New Zealand Ministry of Health, Auckland, New Zealand, ¹⁹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²⁰Rheumatology, Immunology & Allergy, Brigham & Women's Hospital, Boston, MA
Background/Purpose: EULAR and ACR are supporting multi-phase development of SLE classification criteria based on weighted criteria and a continuous probability scale. Prior steps included criteria…
Abstract Number: 1590 • 2017 ACR/ARHP Annual Meeting
Prolonged Antimalarial Treatment Increases the Risk for Severe Brady-Arrhythmias in Systemic Lupus Erythematosus
Konstantinos Tselios¹, Dafna D Gladman², Paula Harvey³, Jiandong Su⁴ and Murray Urowitz⁵, ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Cardiology, Women's College Hospital, University of Toronto, Toronto, ON, Canada, ⁴University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁵Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Severe brady-arrhythmias [complete atrioventricular block (cAVB) and sick sinus syndrome (SSS)] have a prevalence of 0.04% and 0.8% in the general population respectively and…
Abstract Number: 1591 • 2017 ACR/ARHP Annual Meeting
Monophasic Disease Course Pattern in Systemic Lupus Erythematosus
Konstantinos Tselios¹, Dafna D Gladman², Zahi Touma³, Jiandong Su⁴, Nicole Anderson² and Murray Urowitz⁵, ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ⁴University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁵Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Disease course in systemic lupus erythematosus (SLE) is believed to follow three distinct patterns over time, namely relapsing-remitting, persistently active and prolonged quiescent. We…
Abstract Number: 1592 • 2017 ACR/ARHP Annual Meeting
Antimalarial-Induced Cardiomyopathy in Systemic Lupus Erythematosus
Konstantinos Tselios¹, Mery Deeb², Dafna D Gladman³, Paula Harvey⁴, Shadi Akhtari⁴, Susanna Mak⁵, Jagdish Butany⁶ and Murray Urowitz⁷, ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toront, ON, Canada, ³Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁴Cardiology, Women's College Hospital, University of Toronto, Toronto, ON, Canada, ⁵Mecklinger Family and Posluns Family  Cardiac Catheterization Research Laboratory, University of Toronto, Mount Sinai Hospital, Toronto, ON, Canada, ⁶Department of Pathology and Laboratory Medicine, University Health Network, Toronto, ON, Canada, ⁷Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: Antimalarials (AM) are currently recommended for the management of all patients with systemic lupus erythematosus (SLE) without specific contra-indications. Their main adverse effect is…
Abstract Number: 1593 • 2017 ACR/ARHP Annual Meeting
Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan
Nobuyuki Yajima¹, Ken-ei Sada², Shingo Fukuma³, Yasushi Tsujimoto⁴, Sayaka Shimizu³, Kakuya Niihata⁵, Tsuneyo Mimori⁶, Yoshiya Tanaka⁷, Tsutomu Takeuchi⁸, Mayumi Sugiura⁹, Hitoshi Kohsaka¹⁰, Naoto Tamura¹¹, Masataka Kuwana¹², Hideto Kameda¹³, Asano Yoshihide¹⁴, Teruhisa Azuma¹⁵, Toshihiro Matsui¹⁶, Katsuya Suzuki¹⁷, Ryo Takahashi¹, Shunichi Fukuhara³ and Tatsuya Atsumi¹⁸, ¹Div of Rheumatology, Showa University School of Med, Shinagawa-ku Tokyo, Japan, ²Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, ³Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan, ⁴Department of Nephrology and Dialysis, Kyoritsu Hospital, Hyogo, Japan, ⁵Division of Clinical Epidemiology, Fukushima Medical University, FUKUSHIMA, Japan, ⁶Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, ⁷The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, ⁸Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ⁹Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medical sciences, Nagoya, Japan, ¹⁰Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, ¹¹Rheumatology, Juntendo University, Tokyo, Japan, ¹²Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ¹³Division of Rheumatology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan, ¹⁴Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, ¹⁵Satellite for Teaching And Research in General Medicine, Fukushima Medical University, Fukushima, Japan, ¹⁶Department of Lifetime Clinical Immunology Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, ¹⁷Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan, ¹⁸Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
Background/Purpose: A QI set for systemic lupus erythematosus (SLE) was developed in the United States. However, this does not necessarily conform to the Japanese medical…
Abstract Number: 1594 • 2017 ACR/ARHP Annual Meeting
Bone Turnover Markers in Adults with Systemic Lupus Erythematosus
Aliese Sarkissian¹, Vidya Sivaraman², Sharon Bout-Tabaku³, Stacy P. Ardoin⁴, Melissa Moore-Clingenpeel⁵, Holly Steigelman⁶, Kelly Morris⁷ and Sasigarn Bowden⁸, ¹Pediatric Rheumatology, Nationwide Children's Hosptial and The Ohio State University Medical Center, Columbus, OH, ²Pediatric Rheumatology, Nationwide Children's Hospital, Columbus, OH, ³Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁴Pediatrics and Rheumatology, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, ⁵Research, Nationwide Children's Hospital, Dublin, OH, ⁶The Ohio State University Wexner Medical Center, Columbus, OH, ⁷Rheumatology and Immunology, The Ohio State University, Columbus, OH, ⁸Pediatric Endocrinology, Nationwide Children's Hospital and The Ohio State University, Columbus, OH
Background/Purpose: Systemic Lupus Erythematosus (SLE) is a systemic inflammatory disease which has an increased risk for comorbid osteoporosis, related to the disease and long term…
Abstract Number: 1595 • 2017 ACR/ARHP Annual Meeting
Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
Kyung-Eun Lee¹, Ji-Hyoun Kang², Dong-Jin Park² and Shin-Seok Lee², ¹Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South), ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Korea, Republic of (South)
Background/Purpose: Depression is more common in patients with systemic lupus erythematosus (SLE) than in the general population. However, few studies have investigated predictors of depression…
Abstract Number: 1596 • 2017 ACR/ARHP Annual Meeting
Effect of the Metabolic Syndrome on Organ Damage, Renal Function and Mortality in Patients with Systemic Lupus Erythematosus: A Longitudinal Analysis
Chi Chiu Mok¹, Sau Mei Tse¹ and Ling Yin Ho², ¹Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, ²Dept of Medicine, Tuen Mun Hospital, Hong Kong SAR, Hong Kong
Background/Purpose: To study the effect of the metabolic syndrome (MetS) on organ damage, renal function and mortality in patients with SLE. Methods: Consecutive patients who…
Abstract Number: 1597 • 2017 ACR/ARHP Annual Meeting
Arthritis and Hydroxychloroquine Are Associated with Decreased Risk of Macrophage Activation Syndrome Among Adults Hospitalized with SLE
Kristin D'Silva¹, Ezra Cohen², David J. Kreps³, Mary Beth Son² and Karen H. Costenbader³, ¹Internal Medicine, Brigham and Women's Hospital, Boston, MA, ²Boston Children's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Macrophage activation syndrome (MAS) is an uncommon but potentially fatal complication of SLE. We conducted a case-control study comparing hospitalized adults with SLE with…
Abstract Number: 1598 • 2017 ACR/ARHP Annual Meeting
Shrinking Lung Syndrome in Systemic Lupus Erythematosus Patients: A Diagnosis We Should Suspect More Often
Didem Saygin¹, Chris Lau², Marco Lopez-Velazquez³ and Kristin B. Highland⁴, ¹Internal Medicine, Department of Internal Medicine, Cleveland Clinic, Cleveland, Cleveland, OH, ²Pulmonary and Critical Care, Cleveland Clinic, Cleveland, OH, ³Internal Medicine, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology.org, Cleveland Clinic, Cleveland, OH
Background/Purpose: Shrinking lung syndrome (SLS) is a rare pulmonary manifestation of systemic lupus erythematosus (SLE) characterized by dyspnea, pleuritic chest pain, restriction on pulmonary function…
Abstract Number: 1599 • 2017 ACR/ARHP Annual Meeting
GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada
Stephanie Keeling¹, Zainab Alabdurubalnabi², J. Antonio Avina-Zubieta³, Susan Barr⁴, Louise Bergeron⁵, Sasha Bernatsky⁶, Josiane Bourré-Tessier⁷, Ann E. Clarke⁸, Alexandra Baril-Dionne⁹, Jan Dutz², Stephanie Ensworth¹⁰, Aurore Fifi-Mah¹¹, Paul R. Fortin¹², Dafna D Gladman¹³, Derek Haaland¹⁴, John G. Hanly¹⁵, Linda T Hiraki¹⁶, Sara Hussein⁹, Kimberly Legault¹⁷, Deborah M. Levy¹⁶, Lily Lim¹⁸, Mark Matsos¹⁹, Emily McDonald²⁰, Jorge Medina-Rosas²¹, Jordi Pardo Pardo²², Christine A. Peschken²³, Christian Pineau²⁴, Janet E. Pope²⁵, Tamara Rader²⁶, Jennifer Reynolds², Earl Silverman¹⁶, Manon Suitner⁹, Konstantinos Tselios²⁷, Murray Urowitz²⁸, Zahi Touma²⁹, Evelyne Vinet³⁰ and Nancy Santesso¹⁷, ¹Department of Medicine, University of Alberta, Division of Rheumatology, Edmonton, AB, Canada, ²Medicine, University of British Columbia, Vancouver, BC, Canada, ³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ⁴Medicine, University of Calgary, Calgary, AB, Canada, ⁵Canadian Arthritis Patient Alliance, Toronto, ON, Canada, ⁶Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁷Rheumatology, University of Montreal, Montreal, QC, Canada, ⁸Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ⁹Université de Montréal, Montreal, QC, Canada, ¹⁰University of British Columbia, Vancouver, BC, Canada, ¹¹University of Calgary, Calgary, AB, Canada, ¹²Medicine, CHU de Quebec - Universite de Laval, Quebec, QC, Canada, ¹³Centre for Prongosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Krembil Research Institute, Toronto, ON, Canada, ¹⁴Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada, ¹⁵Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ¹⁶Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁷McMaster University, Hamilton, ON, Canada, ¹⁸Hospital for Sick Children, Toronto, ON, Canada, ¹⁹Medicine, McMaster University, McMaster, ON, Canada, ²⁰Medicine, McGill University, Montreal, QC, Canada, ²¹Rheumatology, Universidad de la Sabana, Bogota, Colombia, ²²Centre for Practice Changing Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ²³RR 149G, Univ of Manitoba, Winnipeg, MB, Canada, ²⁴Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ²⁵Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ²⁶The Ottawa Hospital - General Campus, Trials Search Coordinator Knowledge Translation Specialist Cochrane Musculoskeletal Group Centre for Practice Changing Research, Ottawa, ON, Canada, ²⁷Medicine, University of Toronto, Toronto, ON, Canada, ²⁸Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²⁹Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ³⁰Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: To develop GRADE-based recommendations for the diagnosis and monitoring of systemic lupus erythematosus patients in Canada.Methods: Recommendations were developed using the GRADE (Grading of…
Abstract Number: 1600 • 2017 ACR/ARHP Annual Meeting
Lupus Nephritis Is Associated with Increased Rates of Hospitalization for Adverse Events on a Glucocorticoid Toxicity Index and in-Hospital Mortality Compared with Non-Renal Lupus and Matched Controls: An Analysis of Insurance Claims Data
Katherine Belendiuk¹, Huong Trinh², Matthew Cascino¹, Leonard Dragone¹, Daniel Keebler¹, Jay Garg¹ and Paul Brunetta¹, ¹Genentech, Inc., South San Francisco, CA, ²Genentech, South San Francisco, CA
Background/Purpose: Systemic lupus erythematosus (SLE) is heterogeneous in its clinical prognosis and lupus nephritis (LN) is a major cause of morbidity and mortality among children…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].